Electrochemotherapy for large cutaneous recurrence of breast cancer: A phase II clinical trial

By Matthiessen Louise Wichmann   Johannesen Helle Hjorth   Hendel Helle Westergren   Moss Timothy   Kamby Claus   Gehl Julie  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 713-721

Informa Healthcare

Access to resources Recommend Favorite

Phase II study of liposome-complexed mitoxantrone in patients with advanced breast cancer

By Pestalozzi B.C.   Vass A.   Adam H.   Horber D.H.   Schwendener R.A.   Sauter C.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 1024-1024

Elsevier

Access to resources Recommend Favorite

Phase II Study of Semisynthetic Paclitaxel in Metastatic Breast Cancer

By Hudis C.   Riccio L.   Holmes F.   Seidman A.   Baselga J.   Currie V.   Fennelly D.   Gilewski T.   Moynahan M.   Raptis G.   Sklarin N.   Surbone A.   Uhlenhopp M.   Maickel N.   Yao T.J.   Hellmann S.   Usakewicz J.   Hortobagyi G.   Norton L.  

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2198-2202

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Paclitaxel in Advanced Breast Cancer Resistant to Anthracyclines

By Fountzilas G.   Athanassiades A.   Giannakakis T.   Bafaloukos D.   Karakousis K.   Dombros N.   Kosmidis P.   Skarlos D.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Lonidamine plus Epirubicin and Cyclophosphamide in Advanced Breast Cancer. A Phase II Study

By Gardin G.   Barone C.   Nascimben O.   Ianniello G.   Sturba F.   Contu A.   Pronzato P.   Rosso R.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 176-177

Elsevier

Access to resources Recommend Favorite